Intuitive Surgical, Inc. $ISRG Shares Bought by Vestor Capital LLC

Posted by Francis Steltz on Jul 31st, 2026

Vestor Capital LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 97.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,083 shares of the medical equipment provider’s stock after buying an additional 5,462 shares during the period. Vestor Capital LLC’s holdings in Intuitive Surgical were worth $5,109,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. State Street Corp grew its holdings in Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after acquiring an additional 162,264 shares during the period. Capital World Investors raised its position in Intuitive Surgical by 1.7% in the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after acquiring an additional 127,526 shares in the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $2,856,987,000. Invesco Ltd. lifted its holdings in Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the last quarter. Finally, Bank of America Corp DE boosted its position in shares of Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. Sanford C. Bernstein lowered their price objective on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Wells Fargo & Company restated an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Bank of America decreased their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Finally, Truist Financial dropped their price target on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Twenty research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $509.02.

Read Our Latest Report on Intuitive Surgical

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: UBS upgraded ISRG, arguing that the selloff has been excessive. The call provides a counterpoint to recent target reductions and may support a rebound thesis as investors refocus on the company’s recurring instrument revenue and installed da Vinci system base. UBS upgrades Intuitive Surgical
Positive Sentiment: Intuitive Surgical is expanding robotic-assisted surgery beyond its traditional urology strength, with general surgery and newer specialties offering additional long-term procedure growth opportunities. Robotic surgery expansion beyond urology
Neutral Sentiment: HSBC downgraded ISRG from Buy to Hold but assigned a $391 price target, implying upside from recent levels. The mixed analyst signals reflect uncertainty about near-term growth rather than a fundamental change to the company’s long-term opportunity.
Neutral Sentiment: Executive Vice President Mark Brosius sold small blocks of shares under a pre-arranged Rule 10b5-1 plan. The transactions totaled roughly $20,000 and reduced his holdings by about 2% in each sale, limiting their significance for investors. Intuitive Surgical insider sale
Negative Sentiment: Investors remain concerned that U.S. procedure growth could soften and that deferred care may weigh on near-term utilization. Those concerns overshadowed the latest quarterly beat, in which revenue rose 18.4% year over year to $2.89 billion and EPS reached $2.80 versus the $2.48 consensus. Intuitive Surgical post-earnings selloff

Intuitive Surgical Trading Down 0.0%

NASDAQ ISRG opened at $352.97 on Friday. The stock’s 50-day moving average price is $399.96 and its two-hundred day moving average price is $452.67. The company has a market cap of $124.70 billion, a PE ratio of 40.43, a PEG ratio of 2.55 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the firm earned $1.81 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 6,606 shares of company stock worth $2,786,967 in the last 90 days. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.